These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3562461)

  • 21. Complement and disease: a review.
    Adinolfi M; Zenthon J
    J R Soc Med; 1982 Feb; 75(2):121-3. PubMed ID: 7040652
    [No Abstract]   [Full Text] [Related]  

  • 22. Complement proteins and complement inhibitors in Alzheimer's disease.
    McGeer PL; McGeer EG
    Res Immunol; 1992; 143(6):621-4. PubMed ID: 1455053
    [No Abstract]   [Full Text] [Related]  

  • 23. Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.
    Gasque P; Neal JW; Singhrao SK; McGreal EP; Dean YD; Van BJ; Morgan BP
    Mol Neurobiol; 2002 Feb; 25(1):1-17. PubMed ID: 11890454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimeric tyrosine sulfate acts as an endothelial cell protectant and prevents complement activation in xenotransplantation models.
    Laumonier T; Walpen AJ; Matozan KM; Korchagina EY; Bovin NV; Haeberli A; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 May; 11(3):262-8. PubMed ID: 15099206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Complement system: biological functions].
    Santaella ML
    Bol Asoc Med P R; 1981 May; 73(5):209-15. PubMed ID: 7034739
    [No Abstract]   [Full Text] [Related]  

  • 26. [General comments on complement].
    Belisario A; Modiano A; Cipolla C; D'Antuono G
    G Clin Med; 1980 Mar; 61(3):169-76. PubMed ID: 7390090
    [No Abstract]   [Full Text] [Related]  

  • 27. [Complement and its role in the process of inflammation].
    Wize J
    Acta Physiol Pol; 1983; 34 Suppl 25():1-18. PubMed ID: 6202093
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological manipulation of the complement system in human diseases.
    Asghar SS
    Front Biosci; 1996 Mar; 1():e15-25. PubMed ID: 9159241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo studies to prevent hyperacute rejection.
    Miyagawa S; Mikata M; Matsuda H; Ikawa M; Okabe M; Nagasawa S; Matsumoto M; Seya T; Shirakura R
    Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217
    [No Abstract]   [Full Text] [Related]  

  • 30. Cancer research center hotline: complement depletion: use of human C3/cobra venom factor (CVF) chimeric proteins as therapeutic agents.
    Fritzinger DC
    Hawaii Med J; 2005 May; 64(5):133-4, 137. PubMed ID: 15989147
    [No Abstract]   [Full Text] [Related]  

  • 31. Complement-dependent platelet degradation and anaphylactoid shock in mice induced by lipopolysaccharide carrying the mannose homopolymer.
    Endo Y; Yokochi T; Matsushita M; Fujita T; Takada H
    J Endotoxin Res; 2001; 7(6):451-5. PubMed ID: 11753216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blood platelets, prostaglandin and complement interactions in inflammation].
    Myśliwiec M; Myśliwiec B
    Przegl Lek; 1982; 39(6):437-40. PubMed ID: 6753039
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of complement in trauma.
    Heideman M
    Acta Chir Scand Suppl; 1985; 522():233-44. PubMed ID: 3892999
    [No Abstract]   [Full Text] [Related]  

  • 34. [Usefulness of FUT-175 in complement measurements].
    Porcel JM; Ordi J; Gené T; Rodrigo MJ
    Med Clin (Barc); 1994 Mar; 102(8):318. PubMed ID: 8170234
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibitors of the complement system currently in development for cardiovascular disease.
    Pugsley MK; Abramova M; Cole T; Yang X; Ammons WS
    Cardiovasc Toxicol; 2003; 3(1):43-70. PubMed ID: 12668890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The regulation of complement activity by pharmacologic agents.
    Reynard AM
    J Immunopharmacol; 1980; 2(1):1-47. PubMed ID: 6256451
    [No Abstract]   [Full Text] [Related]  

  • 37. Complement therapeutics; history and current progress.
    Morgan BP; Harris CL
    Mol Immunol; 2003 Sep; 40(2-4):159-70. PubMed ID: 12914822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement: a brief review.
    Frank MM
    J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 1):411-20. PubMed ID: 2677090
    [No Abstract]   [Full Text] [Related]  

  • 39. Developments in anti-complement therapy; from disease to clinical trial.
    Harris CL; Pouw RB; Kavanagh D; Sun R; Ricklin D
    Mol Immunol; 2018 Oct; 102():89-119. PubMed ID: 30121124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relevance of complement to virus biology.
    Blue CE; Spiller OB; Blackbourn DJ
    Virology; 2004 Feb; 319(2):176-84. PubMed ID: 15015499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.